Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

education programme

- PMLiVE

Omontys terminal as Takeda switches off support

Japanese company ends anaemia treatment partnership with Affymax

- PMLiVE

Sanofi and Medtronic to develop drug-device combos in diabetes

Companies tell PMLiVE their new alliance will take an ‘open innovation’ approach

- PMLiVE

ADA: AZ plans to file Onglyza/Forxiga pill by year-end

Diabetes prospects could help justify decision to turn down Pfizer bid

- PMLiVE

Breathing new life into pharma’s innovation engine

The rise of new collaborative approaches to R&D

- PMLiVE

ADA: Lilly/Boehringer insulin glargine matches Lantus

Biosimilar demonstrates equal efficacy to Sanofi’s big-selling diabetes treatment

AbbVie closes in on US approval of all-oral hepatitis C regimen

FDA grants priority review to company’s protease inhibitor ABT-450 regimen

- PMLiVE

Sanofi US takes to Pinterest for more visual sharing

Adds the online pin board to its social media toolkit

- PMLiVE

NHS England takes aim at medicines optimisation

New dashboard to support patients' medicine use has pharma support

- PMLiVE

EMA: We will allow clinical data download

Regulator says it hasn't watered down trial transparency measures

Oncology drugs under AMNOG: part two

Patient-relevant outcomes and the 'added benefit' of cancer drugs

- PMLiVE

Cello Health Insight appoints new digital director

Dan Brilot joins from YouGov

- PMLiVE

AstraZeneca has clearer route to Movantik approval in US

Won't have to carry out cardiovascular outcomes study prior to approval

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links